APC mutation promotes CRC initiation through the activation of β-catenin and transcription-factor-4 (TCF4) complex which targets tumor progression-promoting genes, such as Myc, cyclin D1, and matrix metallopeptidase 7 (MMP7) [157,158,159,160,161]. Here, TCF4 is linked to neoplasm.